Objectives:

1. Understand the molecular pathophysiological mechanisms underlying diastolic dysfunction.

2. Learn how Rho kinase (ROCK) can influence cardiac remodeling.

3. Appreciate the therapeutic role of ROCK inhibitors in HFpEF.

 

Session date: 
Friday, March 2, 2018 - 12:00pm to 1:00pm
Speaker Name: 
James K. Liao, MD
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.